These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 10934733)

  • 1. Evaluation of high molecular weight poly(oxyethylene) (Polyox) polymer: studies of flow properties and release rates of furosemide and captopril from controlled-release hard gelatin capsules.
    Efentakis M; Vlachou M
    Pharm Dev Technol; 2000; 5(3):339-46. PubMed ID: 10934733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two- and three-layer tablet drug delivery systems for oral sustained release of soluble and poorly soluble drugs.
    Efentakis M; Naseef H; Vlachou M
    Drug Dev Ind Pharm; 2010 Aug; 36(8):903-16. PubMed ID: 20196641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation parameters affecting the performance of coated gelatin capsules with pulsatile release profiles.
    Bussemer T; Bodmeier R
    Int J Pharm; 2003 Nov; 267(1-2):59-68. PubMed ID: 14602384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Release of furosemide from multiple-unit and single-unit preparations containing different viscosity grades of sodium alginate.
    Efentakis M; Koutlis A
    Pharm Dev Technol; 2001; 6(1):91-8. PubMed ID: 11247279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged-release hard gelatin capsules of furosemide for the treatment of dogs.
    Smal J; Haapala O; Marvola M; Kuusela S; Happonen I
    J Vet Pharmacol Ther; 1995 Feb; 18(1):17-23. PubMed ID: 7752301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dielectric and thermodynamic properties of biodegradable poly(D,L-lactide-co-glycolide) and the effect on the micro-encapsulation and release of captopril.
    Schartel B; Volland C; Li YX; Wendorff JW; Kissel T
    J Microencapsul; 1997; 14(4):475-88. PubMed ID: 9229347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The filling of molten and thixotropic formulations into hard gelatin capsules.
    Walker SE; Ganley JA; Bedford K; Eaves T
    J Pharm Pharmacol; 1980 Jun; 32(6):389-93. PubMed ID: 6106669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatty acid and water-soluble polymer-based controlled release drug delivery system.
    Desai D; Kothari S; Chen W; Wang J; Huang M; Sharma L
    J Pharm Sci; 2011 May; 100(5):1900-12. PubMed ID: 21374622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulating drug release profiles by lipid semi solid matrix formulations for BCS class II drug--an in vitro and an in vivo study.
    M K; Sistla R; Shastri NR
    Drug Deliv; 2015 May; 22(3):418-26. PubMed ID: 24471823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation and pharmacodynamic evaluation of captopril sustained release microparticles.
    El-Kamel AH; Al-Shora DH; El-Sayed YM
    J Microencapsul; 2006 Jun; 23(4):389-404. PubMed ID: 16854815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of various surfactants and their concentration on controlled release of captopril from polymeric matrices.
    Nokhodchi A; Hassan-Zadeh D; Monajjem-Zadeh F; Taghi-Zadeh N
    Acta Pharm; 2008 Jun; 58(2):151-62. PubMed ID: 18515225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of the dissolution characteristics of capsule and tablet dosage forms of melt granulations of paracetamol--diluent effects.
    Uhumwangho MU; Okor RS
    Acta Pol Pharm; 2007; 64(1):73-9. PubMed ID: 17665854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of active pharmaceutical material release from a novel 'tablet in capsule system' containing an effervescent blend.
    Gohel MC; Sumitra G M
    J Control Release; 2002 Feb; 79(1-3):157-64. PubMed ID: 11853927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Water migration from soft gelatin capsule shell to fill material and its effect on drug solubility.
    Serajuddin AT; Sheen PC; Augustine MA
    J Pharm Sci; 1986 Jan; 75(1):62-4. PubMed ID: 3958908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of Polymer Type on the Physical Properties and Release Profile of Papaverine Hydrochloride From Hard Gelatin Capsules.
    Polski A; Iwaniak K; Kasperek R; Modrzewska J; Sobótka-Polska K; Sławińska K; Poleszak E
    Polim Med; 2015; 45(2):51-5. PubMed ID: 26994886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of polymorphism on the manufacturability and in vitro dissolution of sulindac-containing hard gelatin capsules.
    Guadalupe Sánchez-González E; Yépez-Mulia L; Jesús Hernández-Abad V; Jung Cook H
    Pharm Dev Technol; 2015 May; 20(3):306-13. PubMed ID: 24417644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Floating solid cellulose nanofibre nanofoams for sustained release of the poorly soluble model drug furosemide.
    Svagan AJ; Müllertz A; Löbmann K
    J Pharm Pharmacol; 2017 Nov; 69(11):1477-1484. PubMed ID: 28809440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulsatile drug release from an insoluble capsule body controlled by an erodible plug.
    Krögel I; Bodmeier R
    Pharm Res; 1998 Mar; 15(3):474-81. PubMed ID: 9563080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges and opportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administration.
    Cole ET; Cadé D; Benameur H
    Adv Drug Deliv Rev; 2008 Mar; 60(6):747-56. PubMed ID: 18096270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SYNTHESIS AND IN VITRO CHARACTERIZATION OF HYDROXYPROPYL METHYLCELLULOSE-GRAFT-POLY (ACRYLIC ACID/2-ACRYLAMIDO-2-METHYL-1-PROPANESULFONIC ACID) POLYMERIC NETWORK FOR CONTROLLED RELEASE OF CAPTOPRIL.
    Furqan Muhammad I; Mahmood A; Aysha R
    Acta Pol Pharm; 2016; 73(1):183-96. PubMed ID: 27008813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.